Invex Therapeutics Ltd.ASX: IXC

Initial FDA and EMA Advice on Presendin Development

Jul 23, 2020 at 3:43 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment